Latest News
Nike's stock has fallen 70% from its 2021 high, but there are signs of life if you don't mind taking on a turnaround story.
Via The Motley Fool · April 19, 2026
This semiconductor testing provider saw a notable insider sale amid a year of pronounced share price gains and declining executive holdings.
Via The Motley Fool · April 19, 2026
USA Rare Earth is beating the stock market in 2026, yet still trades over 45% below a recent high. Should you buy?
Via The Motley Fool · April 19, 2026
Via Talk Markets · April 19, 2026
Forget the recent, noisy headlines. Think bigger-picture, and recognize these pullbacks are likely to only be short-lived.
Via The Motley Fool · April 19, 2026
Mining stocks are in a prime position to benefit as precious metals prices remain elevated.
Via The Motley Fool · April 19, 2026
Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its core market.
Via The Motley Fool · April 19, 2026
Amazon isn't the first company investors think of when it comes to AI.
Via The Motley Fool · April 19, 2026
Explore how differences in portfolio focus and risk profiles set these two core bond ETFs apart for income-minded investors.
Via The Motley Fool · April 19, 2026
TSMC's stock couldn't get a lift from the strong outlook in its latest earnings report.
Via The Motley Fool · April 19, 2026
This ETF targets downgraded U.S. corporate bonds, providing diversified high yield exposure via an index-driven approach.
Via The Motley Fool · April 19, 2026
The third quarter begins in July, and UPS' management believes it will mark the inflection point for the turnaround.
Via The Motley Fool · April 19, 2026
America’s largest wholesale mortgage lender reported a notable insider sale amid a year of declining share prices.
Via The Motley Fool · April 19, 2026
Investors who are worried about the future can look to these stable and predictable businesses.
Via The Motley Fool · April 19, 2026
You may be surprised to learn how much you can personally benefit from the closing of the donut hole.
Via The Motley Fool · April 19, 2026

Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.
Via The Motley Fool · April 19, 2026
This week, crypto buzzed with Binance growth, $1M Bitcoin calls, Ethereum bets, Dogecoin buying, and political tensions.
Via Benzinga · April 19, 2026
Google is in talks with Marvell to produce new versions of its AI chips, called TPUs, say reports. Growing AI chips sales could boost Google stock.
Via Investor's Business Daily · April 19, 2026
Are you wondering how to deploy the $7,000 TFSA contribution? These three very different Canadian stocks could set you up for a big win.
Via The Motley Fool · April 19, 2026
Explore how each ETF’s unique bond mix shapes risk and diversification for short-term investors weighing safety versus broader exposure.
Via The Motley Fool · April 19, 2026
You'll slash your benefits, but there's much more to the story.
Via The Motley Fool · April 19, 2026
Explore how differing bond exposures and cost structures set these two long-term ETFs apart for income-focused portfolios.
Via The Motley Fool · April 19, 2026